Aptose Biosciences Secures $4.43 Million Funding
Company Announcements

Aptose Biosciences Secures $4.43 Million Funding

Aptose Biosciences (TSE:APS) has released an update.

Aptose Biosciences Inc. has successfully completed a registered direct offering, raising approximately $4.43 million by selling common shares at $1.15 each, as well as issuing series A and B warrants. The proceeds are intended for working capital and general corporate use. H.C. Wainwright & Co. facilitated the transaction as the exclusive placement agent.

For further insights into TSE:APS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAptose Biosciences Reports Q3 2024 Financial Highlights
TipRanks Canadian Auto-Generated NewsdeskAptose Biosciences Advances AML Triplet Therapy
Christine BrownAPTO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App